Paul Fleming is Technical Director of the British Generic Manufacturers Association (BGMA) and the British Biosimilars Association (BBA). These roles include working with MHRA, Department of Health and Social Care, the NHS, UK Government and other stakeholders. Paul has 20 years experience from working in the generic sector of the European pharmaceutical industry, in a variety of senior board level roles covering R&D, drug regulation, clinical development and leadership. Paul is a pharmacist by training and in his early years worked with the UK medicines regulator, the MHRA, as a principal pharmaceutical assessor. Throughout his professional life he has maintained an involvement with the science of pharmaceutical development connecting to how medicines can be used for the maximum benefit of patients and the NHS.